Dernière minute
Newsgather

cholesterol

Stable20 articles9 sourcesDernière mise à jour: 13/07/2026

Derniers articles

Obesity and Cardiovascular Health: Cholesterol and Blood Pressure Levels Similar to Healthy Weights Due to Medication
En développement
Santé·02/07/2026Résumé IA

Obesity and Cardiovascular Health: Cholesterol and Blood Pressure Levels Similar to Healthy Weights Due to Medication

A study found that many adults with obesity have cholesterol and blood pressure levels indistinguishable from those of healthy weight, largely due to statins and blood pressure medication. The findings are particularly notable in individuals aged 40 and over, suggesting a convergence of cardiovascular risk factors.

G
Guardian UK
3 min de lecture
Obese Adults Have Similar Cholesterol and Blood Pressure to Healthy Weight Individuals, Study Finds
En développement
Santé·02/07/2026Résumé IA

Obese Adults Have Similar Cholesterol and Blood Pressure to Healthy Weight Individuals, Study Finds

A study published in The Lancet reveals that many obese adults, particularly those over 40, now have cholesterol and blood pressure levels comparable to healthy-weight individuals, largely due to the widespread use of statins and blood pressure medications. Researchers examined data from nearly 1 million adults across several countries, finding that these risk factors have converged, though obesity still poses risks for younger adults and other health conditions.

G
Guardian UK
4 min de lecture
Being Young And Fit No Longer Protects You From High Cholesterol: Doctor Shares Prevention Tips
En développement
Santé·28/04/2026Résumé IA

Being Young And Fit No Longer Protects You From High Cholesterol: Doctor Shares Prevention Tips

Abnormal cholesterol is emerging as a silent epidemic among young Indians, with 25-30% of urban youth and 15-20% of rural youth already having elevated levels. Nearly one in five at-risk individuals remain undiagnosed. A 2026 study shows nearly two in five Indian adolescents have dyslipidemia, with low HDL being the most prevalent abnormality. Dr R Govindarajan advises baseline lipid screening between ages 20-25, daily movement, and fiber-rich nutrition as prevention strategies.

T
Times of India
4 min de lecture
Pharma Bets Big on Lp(a) Cholesterol Drugs With $5.6B Market Potential
En développement
Santé·27/04/2026Résumé IA

Pharma Bets Big on Lp(a) Cholesterol Drugs With $5.6B Market Potential

Novartis, Amgen and Eli Lilly are in late-stage trials for drugs targeting Lp(a), a dangerous form of cholesterol affecting one in five people worldwide. Novartis expects Phase 3 results mid-2026 for pelacarsen, with Amgen and Lilly following in 2027 and 2029. The drugs have shown 80%+ Lp(a) reduction but must now prove clinical benefit. If successful, the market could reach $5.6B by 2032, though less than 1% of U.S. adults currently get tested for Lp(a).

C
CNBC
4 min de lecture